Description

Creative Biomart, a US-based biotechnology company providing technologies and services for the rapid development of high-performance stable cell lines has launched an expanded offering that focuses on the biosimilar cell lines.

Creative Biomart scientists developed the biosimilar stable cell lines with its proprietary gene screening and amplification system that combines its unique technique platforms and its cell culture know-how for the rapid development of biosimilars products.

These manufacturing cell lines have been accepted by CMO's and manufacturers worldwide to produce cGMP material, including antigen-binding fragment, monoclonal antibody, single-chain variable fragment and other Biosimilar Cell Lines.

“We are delighted to offer fully integrated products and services to our client worldwide by incorporating biosimilar expressing cell lines. Particularly in support of this new launch, we are also expanding our support of product and service capabilities which will further enhance the value of this package". The marketing director of Creative Biomart commented.

Creative Biomart is a pioneer and undisputed global leader for offering biosimilar cell lines. For more product information, please visit http://www.creativebiomart.net/recombinantproteins-Biosimilar-Cell-Lines.htm.